§ PHARMACEUTICALS
USD · PharmaceuticalsANRO
ALTO NEUROSCIENCE INC
USDSector · Pharmaceuticals
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
69 increased/new, 31 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Alpha Wave Global, LP | 3.7M | 10.5% | ±0% |
| Commodore Capital LP | 2.7M | 3.5% | +49% |
| Vivo Capital, LLC | 2.1M | n/a | +100% |
| Vestal Point Capital, LP | 2.1M | 1.3% | −17% |
| PERCEPTIVE ADVISORS LLC | 2.0M | n/a | +13% |
| Spruce Street Capital LP | 1.3M | 7.0% | +495% |
◇ AC INTELLIGENCE
Top institutional owners for ANRO as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER89.2% · 69 holders
QUALITY / COMPOUNDER5.2% · 10 holders
PASSIVE / INDEX3.2% · 4 holders
DEALER / BANK3.1% · 16 holders
TACTICAL / MACRO3.0% · 4 holders
SYSTEMATIC / QUANT1.1% · 6 holders
ACTIVIST0.1% · 1 holder
INCOME / DEFENSIVE0.1% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ANRO in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention ANRO yet.